FDA Expands AI Capabilities and Completes Data Platform Consolidation

Persistent Achieves Databricks Brickbuilder Specialization for Healthcare & Life Sciences, Expanding Production-Ready Data and AI Solutions For Regulated Environments

SANTA CLARA, Calif. and PUNE, India, May 7, 2026

FDA Expands AI Capabilities and Completes Data Platform Consolidation

White Oak, Md., May 06, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced major steps in its bold initiative to modernize the agency. The agency launched Elsa 4.0, a significant upgrade to the agency's internal AI tool available to all FDA staff, from scientific reviewers to investigators.   The agency also consolidated more than 40 disparate application and submission data sources, systems and portals across all FDA…

FDA launches updated AI and consolidated data platform

The Food and Drug Administration announced on Wednesday that it has launched an updated version of its internal artificial intelligence tool, called Elsa, that is being integrated with a consolidated data platform to enable faster search capabilities. Elsa 4.0 now features expanded access to disparate agency information within a new consolidated data platform, called the Harmonized AI & Lifecycle Operations for Data. By merging HALO and Elsa, st…